期刊文献+

18F-FDG PET/CT显像诊断心包恶性病变的价值 被引量:4

18F-FDG PET/CT in diagnosis of malignant pericardial lesions
原文传递
导出
摘要 目的 评价18F-脱氧葡萄糖(FDG)PET/CT对心包恶性病变的诊断价值.方法 对23例心包积液患者进行18F-FDG PET/CT显像,并采用两独立样本非参数检验分析良恶性病灶最大标准摄取值(SUVmax)差异有无统计学意义.结果 经病理检查证实恶性心包积液14例,良性心包积液9例.1例PET/CT假阴性,2例PET/CT假阳性.18F-FDG PET/CT鉴别诊断良恶性心包积液的灵敏度、特异性、准确性、阳性预测值、阴性预测值分别为92.9%(13/14)、7/9、87.0%(20/23)、86.7%(13/15)和7/8.良、恶性病变的SUVmax中位值分别为2.2和6.0,两者间比较差异有统计学意义(z=-3.279,P=0.001).结论 18F-FDG PET/CT是评价心包恶性病变较好的无创性手段,对良恶性心包积液的诊断与鉴别诊断有一定临床价值. Objective To assess the value of integrated 18 F-fluorodeoxyglucose (FDG) PET/CT in differentiation of malignant and benign pericardial effusion. Methods 18F-FDG PET/CT were performed in 23 patients with pericardial effusion. The detected soft tissue tumor or nodulous lession in pericardium or the thickened pericardium, with the maximum standardized uptake value( SUVmax ) ≥2.5, was defined as PET/CT-positive. The invaded lession in pericardium with SUVmax ≥2.5 was also as the positive. The difference of SUVmax of benign and malignant lesions was analyzed with two-independent-sample test of nonparametric tests. The final diagnosis was confirmed by biopsy or post-operative pathology. Results The diagnosis were confirmed with 14 malignant and 9 benign lesions. The median of SUVmax was 6.0 in malignancy group and 2.2 in benign group (z= -3. 279, P =0.001 ). According to the pathology results, there were one false negative case and two false positive cases with PET/CT imaging interpretation. The sensitivity, specificity,accuracy, positive predictive value ( PPV ) and negative predictive value ( NPV ) of 18 F-FDG PET/CT in diagnosis of benignity or malignance of pericardium effusion were 92.9% ( 13/14), 7/9, 87.0% (20/23),86.7% (13/15) and 7/8, respectively. Conclusion For the patients with pericardium effusion 18F-FDG PET/CT may be a helpful modality for malignancy differentiation
出处 《中华核医学杂志》 CAS CSCD 北大核心 2010年第5期333-335,共3页 Chinese Journal of Nuclear Medicine
关键词 心包积液 肿瘤 体层摄影术 发射型计算机 体层摄影术 X线计算机 脱氧葡萄糖 Pericardial effusion Neoplasms Tomography, emission-computed Tomography, X-ray computed Deoxygluxose
  • 相关文献

参考文献6

二级参考文献41

  • 1许尚文,彭旭红,曾建华,段刚.肝脏局灶性结节增生的螺旋CT和MRI诊断[J].放射学实践,2004,19(10):733-736. 被引量:8
  • 2李园.肝内胆管细胞癌的诊断与治疗进展[J].临床肿瘤学杂志,2004,9(6):666-668. 被引量:25
  • 3李正平,周杰,张峻,崔忠林.F-18 FDG-PET在原发性肝癌中的诊断作用[J].肝胆外科杂志,2005,13(5):351-354. 被引量:5
  • 4Uldry M,Ibberson M,Horisberger JD,et al.Identification of a mammalian H + -myo-inositol symporter expressed predominantly in the brain.Embo J,2001,20:4467-4477. 被引量:1
  • 5Younes M,Lechago LV,Somoano JR,et al.Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers.Cancer Res,1996,56:1164-1167. 被引量:1
  • 6Macheda ML,Rogers S,Best JD.Molecular and cellular regulation of glucose transporter (Glut) proteins in cancer.J Cell Physiol,2005,202:654-662. 被引量:1
  • 7Brown RS,Wahl RL.Overexpression of Glut1 glucose transporter in human breast cancer.An immunohistochemical study.Cancer,1993,72:2979-2985. 被引量:1
  • 8Younes M,Lechago LV,Somoano JR,et al.Immunohistochemical detection of Glut3 in human tumors and normal tissues.Anticancer Res,1997,17:2747-2750. 被引量:1
  • 9Higashi K,Ueda Y,Sakurai A,et al.Correlation of Glut1 glucose transporter expression with 18F-FDG uptake in non-small cell lung cancer.Eur J Nucl Med,2000,27:1778-1785. 被引量:1
  • 10Yen TC,See LC,Lai CH,et al.18^F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.J Nucl Med,2004,45:22-29. 被引量:1

共引文献17

同被引文献50

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部